Dr. John Cush RheumNow

6 years 7 months ago

Important acronyms in both Ortho and Rheum. Dr Wm Bugbee at #RWCS2020 @RWCSmtg https://t.co/guqjPwkoFT

Jack Cush, MD

6 years 7 months ago

Science Translational Medicine has a report on how the use of Janus kinase (JAK) inhibitors may boost osteoblasts to battle bone erosions in conditions like rheumatoid arthritis (RA).JAK inhibitors have been shown in clinical trials to retard the development of bone erosions while controlling RA inflammation and other clinical features.

QD Clinic - Dosing RTX and REM

6 years 7 months ago

How I Dose and Use Rituxan or Remicade

Dr. John Cush RheumNow

6 years 7 months ago

QD Clinic - Same Day? Outpatient Hip Replacements? Really? Listen on iTunes or here https://t.co/yinzgxyLgt

http://bit.ly/2ucgcY6

Dr. John Cush RheumNow

6 years 7 months ago

QD Clinic - CPPD and PIP4 - listen to the podcast on iTunes or here ttps://bit.ly/2SVyULW

Dr. John Cush RheumNow

6 years 7 months ago

A study of 319 WOMEN with RA shows a higher rate of depression (30% in RA) compared to healthy controls (12.4%) (p<0.001). Depressive symptoms were strongly associated with disease activity and disability (HAQ, p<0.005). https://t.co/JDRNrR8qMn

http://bit.ly/2SYsJqi

Dr. John Cush RheumNow

6 years 7 months ago

"Success is not final, failure is not fatal: it is the courage to continue that counts." - Winston Churchill

QD Clinic - Weighty Decisions in RA

6 years 7 months ago

Weighing Decisions on Drug D/C, Weaning, Add-ons, etc

Adverse Effects of Low-Dose Methotrexate from the CIRT Trial

Jack Cush, MD

6 years 7 months ago

Low-dose methotrexate (LD-MTX) was studied in high risk cardiac patients in the cardiac intervention trial (CIRT), but was prematurely ended for not showing a change in cardiovascular event rates. Nonetheless this trial studied the safety and adverse event rates of LD-MTX and those results are reported in the current issue of Annals of Internal Medicine.